本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cogent Biosciences, Inc.

29.78
-1.2200-3.94%
盘前:30.190.4050+1.36%04:06 EDT
成交量:185.53万
成交额:5,605.66万
市值:51.68亿
市盈率:-13.79
高:31.07
开:30.81
低:29.63
收:31.00
52周最高:43.73
52周最低:13.78
股本:1.74亿
流通股本:1.67亿
量比:0.80
换手率:1.11%
股息:- -
股息率:- -
每股收益(TTM):-2.1600
每股收益(LYR):-2.5504
净资产收益率:-109.74%
总资产收益率:-43.84%
市净率:11.05
市盈率(LYR):-11.68

数据加载中...

2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/25

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/27

重要事件披露

8-K - Current report
2021/10/05

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/17

重要事件披露

8-K - Current report
2021/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/12

重要事件披露

8-K - Current report
2021/03/16

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/16

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/16

重要事件披露

8-K - Current report
2021/02/22

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals